EOS789, a novel pan-phosphate transporter inhibitor, is effective for the treatment of chronic kidney disease–mineral bone disorder

Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis

Geoffrey A. Block, Preston Klassen, J. Michael Lazarus et al. · Journal of the American Society of Nephrology · 2004 · 2.7K citations

Medicine, Endocrinology, Nephrology +17

Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis

William G. Goodman, Jonathan Goldin, Beatriz D. Kuizon et al. · New England Journal of Medicine · 2000 · 2.5K citations · Full text

Medicine, Nephrology, Radiology +14

CORONARY-ARTERY CALCIFICATION IN YOUNG ADULTS WITH END-STAGE RENAL DISEASE WHO ARE UNDERGOING DIALYSIS

W Illiam G. G Oodman, J Onathan G Oldin, D. K Uizon et al. · 2000 · 2.2K citations

Medicine, Nephrology, Radiology +14

Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

Orlando M. Gutiérrez, Michael Mannstadt, Tamara Isakova et al. · New England Journal of Medicine · 2008 · 1.7K citations · Full text

Medicine, Endocrinology, Nephrology +17

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

Tamara Isakova, Patricia Wahl, Gabriela Vargas et al. · Kidney International · 2011 · 1.2K citations · Full text

Medicine, Endocrinology, Nephrology +16